Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05568160

Evaluation of the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation

Prospective Randomized Double-blind Study Evaluating the Superiority of VAsopressin Versus NOradrenaline in the Management of Patients at Risk of Kidney Failure Undergoing Cardiac Surgery With Extracorporeal Circulation

Status
Active Not Recruiting
Phase
Phase 3
Study type
Interventional
Enrollment
840 (estimated)
Sponsor
Centre Hospitalier Universitaire Dijon · Academic / Other
Sex
All
Age
70 Years
Healthy volunteers
Not accepted

Summary

This is a randomized, double blind, multicenter study following surgery with extracorporeal circulation to compare blood pressure optimization with vasopressin versus noradrenaline. It is planned to include 840 patients in order to have 420 patients with vasoplegic syndrome. The primary objective of this study is to determine whether the use of vasopressin to maintain blood pressure following cardiac surgery decreases the number of patients with acute renal failure and/or death compared with the usual use of norepinephrine. Participation in the study involves daily follow-up at D1, D2, and D7 of the onset of the syndrome and then follow-up at D30 and D90.

Conditions

Interventions

TypeNameDescription
DRUGVasopressinThe infusion is started at 5 ml hr-1, increased in increments of 1 ml hr-1 every 5 minutes to reach a maximum target rate of 30 ml hr-1
DRUGNorepinephrineThe infusion is started at 5 ml h-1, increased in increments of 1 ml h-1 every 5 minutes to a maximum target rate of 30 ml h-1
OTHERCollection of clinical dataAt D1, D2, D7, D30 or D60 and D90
OTHERQuality of Life Questionnaire EQ-5DAt the anesthesia consultation, discharge from intensive care, D7, D30 and D90

Timeline

Start date
2023-01-02
Primary completion
2026-03-01
Completion
2026-03-01
First posted
2022-10-05
Last updated
2025-12-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05568160. Inclusion in this directory is not an endorsement.